Search results
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 13 hours agoPfizer (PFE) closed at $27.41 in the latest trading session, marking a +1.59% move from the prior...
Cantor Fitzgerald Reiterates “Overweight” Rating for Pfizer (NYSE:PFE)
ETF DAILY NEWS· 8 hours agoPfizer (NYSE:PFE – Get Free Report)‘s stock had its “overweight” rating reissued by equities researchers at Cantor Fitzgerald in a report issued on Monday, Benzinga reports ...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
Motley Fool via Yahoo Finance· 21 hours agoWhen it comes to investing in high-yield dividend stocks in the pharmaceutical space, two prominent...
Pfizer stock price analysis: how PFE became a fallen angel | Invezz
Invezz· 24 hours agoPfizer (NYSE: PFE) stock price has crashed hard in the past few years as demand for Covid-19...
...Lobby US Lawmakers For Israel's Support Amid Hamas Attack, Hostage Crisis - Oracle (NYSE:ORCL),...
Benzinga· 3 hours agoThe CEOs of major companies, including Palantir Technologies Inc. PLTR, Oracle Corp. ORCL, and Pfizer Inc. PFE, lobbied U.S. senators for support of Israel during its Gaza ...
Pfizer Inc. (NYSE:PFE) Shares Sold by CoreFirst Bank & Trust
ETF DAILY NEWS· 24 hours agoCoreFirst Bank & Trust decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with ...
Pfizer Inc. (NYSE:PFE) Shares Sold by B. Riley Wealth Advisors Inc.
ETF DAILY NEWS· 24 hours agoB. Riley Wealth Advisors Inc. decreased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 15.0% during the fourth quarter, according to its most recent 13F ...
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 6 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Pfizer (PFE) Stock Declines While Market Improves: Some Information for Investors
Zacks via Yahoo Finance· 7 days agoPfizer (PFE) closed the latest trading day at $27.66, indicating a -1.32% change from the previous...
Kansas sues Pfizer, saying it misled the public over COVID-19 vaccine
Market Watch· 1 day agoThe state of Kansas has filed a lawsuit against Pfizer alleging the company misled the public about...